Simplify Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Simplify Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-90,000	Closed	-$450K	–	134
2024 Q1	$450K	Buy	+90,000	New	+$559K	0.03%	89
2023 Q4	–	Sell	-90,000	Closed	-$824K	–	146
2023 Q3	$824K	Buy	90,000 +53,345	+146%	+$1.07M	0.09%	79
2023 Q2	$774K	Hold	36,655	–	–	0.1%	85
2023 Q1	$986K	Buy	+36,655	New	+$1.7M	0.14%	64

Other funds holding EIGR

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplify Asset Management's EIGR Position: Q2 2024 in Review

Simplify Asset Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2024, closing a stake of 90,000 shares — an estimated $450K sold.

Simplify Asset Management first reported a position in EIGR in Q1 2023 and held it in 4 quarters. The position peaked at $986K in Q1 2023. 2 funds tracked by Wall St. Rank hold EIGR as of Q2 2024.

Simplify Asset Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Simplify Asset Management sold 90,000 Eiger BioPharmaceuticals, Inc. shares in Q2 2024, an estimated $450K.
Simplify Asset Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2023 and held it in 4 quarters.
Simplify Asset Management's Eiger BioPharmaceuticals, Inc. position peaked at $986K in Q1 2023.
2 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2024.

Based on Simplify Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.